Alivus Life Sciences Ltd.

BSE: 543322 | NSE: ALIVUS
Small Cap | Pharmaceuticals & Drugs
912.60
1.55 (0.17%)
< Home < Back

Alivus Life Sciences informs about earnings call transcript

Date: 13-11-2025
Alivus Life Sciences has informed that the transcript of Earnings Call held on Friday, November 7, 2025 for the second quarter and half year ended September 30, 2025 is available on website of the Company at: https://bunny-wp-pullzone-zhbiessutg.bcdn.net/alivus_pdfs/investors/financials/reports_presentation/Transcript_Alivus%20Life%20Scien ces_Earnings%20Call_Q2FY26.pdf.

The above information is a part of company’s filings submitted to BSE.